Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer

被引：0
|
作者：
Reimann, Patrick [1 ,2 ]
Winder, Thomas [1 ,3 ]
机构：
[1] Feldkirch Acad Teaching Hosp, Dept Internal Med 2, Carinagasse 47, A-6800 Feldkirch, Austria
[2] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[3] Univ Zurich, Zurich, Switzerland
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷 / 04期
关键词：
Pancreatic cancer treatment; Primary resectable cancer; Metastatic; Neoadjuvant therapy; First-line treatment; PHASE-II; FOLFIRINOX;
D O I：
10.1007/s12254-023-00931-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this short review, we aim to summarize the essential news and highlights in pancreatic cancer that were presented at ASCO 2023. We focus in particular on primary resectable as well as advanced or metastatic disease. Therefore, the first results of the NORPACT-1 trial and the updated data from the NAPOLI-3 study are summarized. We discuss these studies and their potential influence on daily clinical practice with regard to current standard of care.
引用
收藏
页码：225 / 229
页数：5
相关论文
共 50 条
  • [31] Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer
    Chang, Shih-Chun
    Tang, Chi-Ming
    Le, Puo-Hsien
    Kuo, Chia-Jung
    Chen, Tsung-Hsing
    Wang, Shang-Yu
    Chou, Wen-Chi
    Chen, Tse-Ching
    Yeh, Ta-Sen
    Hsu, Jun-Te
    CANCERS, 2021, 13 (06) : 1 - 18
  • [32] Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed
    Leu, KM
    Zalupski, MM
    ONCOLOGY-NEW YORK, 2001, 15 (10): : 1259 - 1260
  • [33] Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer
    Mancini, Brandon R.
    Stein, Stacey
    Lloyd, Shane
    Rutter, Charles E.
    James, Edward
    Chang, Bryan W.
    Lacy, Jill
    Johung, Kimberly L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 982 - 988
  • [34] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Roberto Alva-Ruiz
    Lavanya Yohanathan
    Jennifer A. Yonkus
    Amro M. Abdelrahman
    Lindsey A. Gregory
    Thorvadur R. Halfdanarson
    Amit Mahipal
    Robert R. McWilliams
    Wen Wee Ma
    Christopher L. Hallemeier
    Rondell P. Graham
    Travis E. Grotz
    Rory L. Smoot
    Sean P. Cleary
    David M. Nagorney
    Michael L. Kendrick
    Mark J. Truty
    Annals of Surgical Oncology, 2022, 29 : 1579 - 1591
  • [35] Clinical utility of circulating tumor DNA in resectable and advanced pancreatic cancer
    Popova, A.
    Fedyanin, M.
    Pokataev, I.
    Shamovskaya, D.
    Kudashkin, N.
    Boyarskikh, U.
    Kechin, A.
    Oscorbin, I.
    Moroz, E.
    Trigolosov, A.
    Filipenko, M.
    Podluzhnyi, D.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S180 - S181
  • [36] Heparanase expression in primary and metastatic pancreatic cancer
    Koliopanos, A
    Friess, H
    Kleeff, J
    Shi, X
    Liao, Q
    Pecker, I
    Vlodavsky, I
    Zimmermann, A
    Büchler, MW
    CANCER RESEARCH, 2001, 61 (12) : 4655 - 4659
  • [37] Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer
    Shaib, Walid L.
    Ip, Andrew
    Cardona, Kenneth
    Alese, Olatunji B.
    Maithel, Shishir K.
    Kooby, David
    Landry, Jerome
    El-Rayes, Bassel F.
    ONCOLOGIST, 2016, 21 (02): : 178 - 187
  • [38] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Alva-Ruiz, Roberto
    Yohanathan, Lavanya
    Yonkus, Jennifer A.
    Abdelrahman, Amro M.
    Gregory, Lindsey A.
    Halfdanarson, Thorvadur R.
    Mahipal, Amit
    McWilliams, Robert R.
    Ma, Wen Wee
    Hallemeier, Christopher L.
    Graham, Rondell P.
    Grotz, Travis E.
    Smoot, Rory L.
    Cleary, Sean P.
    Nagorney, David M.
    Kendrick, Michael L.
    Truty, Mark J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1579 - 1591
  • [39] Metastatic Renal Cell Cancer: Summary from ASCO 2015
    不详
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (7-8): : S158 - S161
  • [40] Primary thromboprophylaxis for ambulatory patients with advanced metastatic pancreatic cancer. A practical implementation of lessons from published experience
    Bozas, G.
    Muazzam, I. A.
    Ilyas, W.
    Maraveyas, A.
    THROMBOSIS RESEARCH, 2016, 140 : S191 - S191
12345